Portfolio (Quarterly)
Guide ↗
E Fund Management Co., Ltd.
· CIK 0001842296| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 81 | CDE | COEUR MNG INC | Basic Materials | 30,464.0 | $497K | 0.01% | -9K | -23.1% | $16.32 | +33.6% |
| 82 | TGTX | TG THERAPEUTICS INC | Healthcare | 9,040.0 | $497K | 0.01% | -12K | -56.3% | $54.94 | -0.9% |
| 83 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 1,323.0 | $492K | 0.01% | -958.0 | -42.0% | $371.67 | -3.8% |
| 84 | BLK | BLACKROCK INC | Financial Services | 511.0 | $491K | 0.01% | -17.0 | -3.2% | $961.56 | +22.2% |
| 85 | EW | EDWARDS LIFESCIENCES CORP | Healthcare | 5,407.0 | $489K | 0.01% | -345.0 | -6.0% | $90.46 | -0.4% |
| 86 | NTRA | NATERA INC | Healthcare | 1,798.0 | $488K | 0.01% | -1K | -37.7% | $271.45 | +24.9% |
| 87 | CDW | CDW CORP | Technology | 3,451.0 | $485K | 0.01% | -72.0 | -2.0% | $140.64 | +4.1% |
| 88 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 13,700.0 | $485K | 0.01% | -5K | -28.5% | $35.39 | +3.9% |
| 89 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 14,334.0 | $479K | 0.01% | -6K | -31.1% | $33.39 | -22.1% |
| 90 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 3,891.0 | $477K | 0.01% | -2K | -35.5% | $122.58 | +20.8% |
| 91 | VRT | VERTIV HOLDINGS CO | Industrials | 1,422.0 | $476K | 0.01% | -10K | -87.1% | $334.82 | -20.7% |
| 92 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 5,841.0 | $476K | 0.01% | -4K | -41.6% | $81.51 | +8.5% |
| 93 | TVTX | TRAVERE THERAPEUTICS INC | Healthcare | 8,328.0 | $473K | 0.01% | -11K | -56.5% | $56.81 | +17.3% |
| 94 | COP | CONOCOPHILLIPS | Energy | 4,531.0 | $471K | 0.01% | -54.0 | -1.2% | $103.96 | +23.9% |
| 95 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 873.0 | $469K | 0.01% | -474.0 | -35.2% | $536.95 | -0.1% |
| 96 | INSM | INSMED INC | Healthcare | 4,375.0 | $466K | 0.01% | -7K | -60.3% | $106.62 | +14.2% |
| 97 | ALKS | ALKERMES PLC | Healthcare | 8,879.0 | $465K | 0.01% | -12K | -57.6% | $52.40 | -7.9% |
| 98 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 5,184.0 | $460K | 0.01% | -2K | -27.6% | $88.78 | +5.7% |
| 99 | PTCT | PTC THERAPEUTICS INC | Healthcare | 5,616.0 | $458K | 0.01% | -3K | -36.6% | $81.57 | -13.1% |
| 100 | HALO | HALOZYME THERAPEUTICS INC | Healthcare | 5,810.0 | $455K | 0.01% | -3K | -33.5% | $78.27 | +36.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
68.9%
Consumer Cyclical
12.9%
Communication Services
4.2%
Financial Services
3.9%
Healthcare
3.4%
Industrials
2.5%
Consumer Defensive
2.3%
Utilities
0.8%
Basic Materials
0.6%
Energy
0.4%